TITLE

A ban on silicone

AUTHOR(S)
Podolsky, D.; Newman, R.J.
PUB. DATE
January 1992
SOURCE
U.S. News & World Report;1/20/92, Vol. 112 Issue 2, p61
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that Food and Drug Administration Commissioner David Kessler last week called for a moratorium on the use of silicone-gel breast implants. New and disturbing evidence about possible ties to serious diseases from the implants; The other choices women still have, including saline implants; No official FDA approval has ever been granted for silicone nor saline implants; TRAM (transverse rectus abdominis myocutaneous) surgery. INSET: Reshaping the breast..
ACCESSION #
9201201301

 

Related Articles

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...

  • Product testing.  // Current Health 1;May92, Vol. 15 Issue 9, p22 

    Discusses the medicine and product testing conducted by the US Food and Drug Administration (FDA). Pharmaceutical tests; How the FDA studies test results; FDA approval; Drug testing in other countries; Tests on food, cosmetics, pesticides; The FDA's concern about food labels; Testing donated blood.

  • Dateline Washington.  // Consumers' Research Magazine;Feb1993, Vol. 76 Issue 2, p6 

    Reports that in January a US District Court judge ruled that the Food and Drug Administration (FDA) is not responsible for $210 million worth of losses incurred by Chilean fruit growers when in 1989, the FDA temporarily banned sales of grapes to the United States. Details of the ruling.

  • The Food and Drug... Coorsh, Richard // Consumers' Research Magazine;Jan1995, Vol. 78 Issue 1, p6 

    Reports on the genetically-engineered food products that passed voluntary Food and Drug Administration (FDA) inspection. Products; Producers.

  • FDA vs. UK approval time. Coorsh, Richard // Consumers' Research Magazine;Jan1996, Vol. 79 Issue 1, p6 

    Reports on a General Accounting Office report stating that the Food and Drug Administration (FDA) processes applications as fast or faster than its counterpart in Great Britain. Plans to reform the FDA.

  • Washington letter.  // DCI;Jan1995, Vol. 156 Issue 1, p8 

    Reports on news that key politicians are out to make significant changes in the United States Food and Drug Administration (FDA). House Speaker Newt Gingrich's plans to replace FDA; FDA rebuilding agendas of conservative Washington think tanks including Washington Legal Foundation and Cato...

  • Washington letter.  // DCI;Jan1995, Vol. 156 Issue 1, p8 

    Reports on the relaxing of Food and Drug Administration (FDA) rules on how much pediatric use information can be included on drug labels in order to facilitate proper drug dosing for children. Extrapolation from adult dosages; Information about drugs' effects on children; Inadequacy of...

  • A defense of the FDA.  // DCI;Mar1995, Vol. 156 Issue 3, p6 

    Reports on the reactions to United States Congress' move to curb or eliminate the U.S. Food and Drug Administration. Possibilities of another thalidomide disaster; Issue on the agency's failure to approve a Danish cardiopump.

Share

Read the Article

Other Topics